½Ã°£ | ÇÁ·Î±×·¥ | ¿¬ÀÚ | ¼Ò¼Ó | |
---|---|---|---|---|
»çȸ | ¹ÚÇظ° | ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ Ãѹ«ÀÌ»ç |
||
18:00-18:50 | µî·Ï ¹× Àú³á½Ä»ç | |||
18:50-19:00 | Àλ縻¾¸ | À±»ó¼· | ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ ȸÀå |
|
¡¡ | ¡¡ | ÁÂÀå | ¾çÁ¤Çö | °Ç±¹ÀÇ´ë |
¡¡ | ¡¡ | Á¤ÆÄÁ¾ | Á¤ÆÄÁ¾¿Ü°úÀÇ¿ø | |
19:00-19:20 | The strength and weakness of VABB in the management of breast disease |
Michael Tiong-Hong Co | The University of Hong Kong |
|
19:20-19:40 | The Evolutionary processes of VABB. The past, present and the future |
¹ÚÇظ° | Â÷ÀÇ°ú´ë | |
19:40-20:00 | ¸¾¸ðÅè Á¤Ã¥ÀÇ ÁøÇà°úÁ¤ ¼Ò°³ ¹× ÃßÈÄ°úÁ¤ Á¦¾È | ¾öÅÂÀÍ | ÇÏÀÌÀ¯¿Ü°úÀÇ¿ø | |
20:00-20:20 | ¸¾¸ðÅèÀÇ ¹ýÀû À̽´¿Í ´ëÀÀ ¹æ¾È | Á¶ÁØÇö º¯È£»ç | ¿ø±¤´ëÇб³¹ý´ë | |
20:20-20:45 | Q&A | ¡¡ | ¡¡ | |
20:45-20:50 | Çà¿î±Ç Ãß÷ ¹× Closing remarks | |||
20:50-21:20 | Hands On Session : Mammotome Revolve, Mammotome Elite | ½ÅÇõÀç | ÇѾçÀÇ´ë | |
±¸º»¿ë | À¯¾ØÀ¯¿Ü°úÀÇ¿ø |